Clinical Trials Logo

Seizures clinical trials

View clinical trials related to Seizures.

Filter by:

NCT ID: NCT01355211 Completed - Clinical trials for Altered Mental Status

Putting Electroencephalography (EEG) in the Emergency Department

Start date: April 2011
Phase: N/A
Study type: Observational

The aim of the proposed research is to compare the diagnostic accuracy of a portable wireless electroencephalography (EEG) device (Biosignal Micro-EEG) to standard EEG in identifying abnormal EEG patterns (mainly non-convulsive seizure and non-convulsive status epilepticus) in emergency department (ED) patients with altered mental status. Comparing the the accuracy of EEG recordings and interpretations of Micro-EEG to those of standard EEG will allow the investigators to assess the utility of this novel device in the ED patients with altered mental status. The unique qualities of Micro-EEG device could potentially facilitate easier access to EEG test in all ED patients. This study will also provide valid information regarding the prevalence of non-convulsive seizure in ED patients with altered mental status.The gold standard for diagnosing non-convulsive seizure would be standard EEG. All study participants will undergo electroencephalography using the two devices (standard EEG and micro-EEG) and a combination of standard electrodes and Electro-Cap in a randomized order: 1. Standard EEG with standard EEG electrodes, 2. Micro-EEG with standard EEG electrodes, and 3. Micro-EEG with Electro-Cap electrodes.

NCT ID: NCT01351727 Completed - Epileptic Seizures Clinical Trials

Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors

Start date: January 2011
Phase: N/A
Study type: Observational

The purpose of this proposed research is to identify individuals in southeastern Arizona aged 65 years and older who have new onset seizures (or newly diagnosed epilepsy) and monitor them for at least two years. In doing so the investigators will be able to describe the public health burden of this condition and to identify factors that predict clinical outcomes and health care needs in this population, using quantitative, administrative, and qualitative data. The aims of this proposed research are 1) to determine the two-year incidence of newly diagnosed epilepsy in the target population, 2) describe health care resource utilization of the target population using Medicare data, 3) validate the use of Medicare beneficiary data to estimate incidence of epilepsy, and 4) describe the burden of this condition in different ethnic groups.

NCT ID: NCT01345097 Completed - Osteoarthritis Clinical Trials

A Short Metaphyseal Fitting Total Hip Arthroplasty in Young and Elderly Patients

Start date: May 2004
Phase: Phase 4
Study type: Interventional

The investigators determined whether 1. new short, metaphyseal-fitting cementless anatomical femoral stem provides major functional improvements 2. radiographically secure implant fixation is achieved with this new stem 3. the bone content is preserved at the baseline level or above at the final follow-up 4. these procedures are associated with early failure and complications.

NCT ID: NCT01338805 Completed - Clinical trials for Partial Onset Seizures

Phase II BGG492 Capsule Extension for Partial Epilepsy

Start date: June 2011
Phase: Phase 2
Study type: Interventional

This long-term extension study will assess the safety, tolerability and efficacy of BGG492 as adjunctive treatment in patients with partial onset seizures.

NCT ID: NCT01338363 Completed - Pneumonia Clinical Trials

Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists

Start date: May 2011
Phase: N/A
Study type: Observational

The purpose of this study is 1. To describe patient characteristics and drug usage among children that are prescribed esomeprazole for the first time and to compare them with patients who are prescribed other proton pump inhibitors (PPIs) or H2-receptor antagonists for the first time. 2. To ascertain all incident hospitalized cases of angioneurotic oedema, pneumonia, gastroenteritis, failure to thrive, convulsions/seizures, acute interstitial nephritis and thrombocytopenia among new users in the three cohorts of esomeprazole, other PPIs and H2-receptor antagonists.

NCT ID: NCT01336621 Completed - Epilepsy Clinical Trials

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS)

IR
Start date: February 21, 2011
Phase: Phase 3
Study type: Interventional

The purpose of this Phase III study is to assess the long-term safety, tolerability and efficacy of flexibly dosed retigabine Immediate Release (IR) as adjunctive therapy in adult subjects with partial-onset seizures. In addition, those subjects who successfully completed 20 weeks of adjunctive treatment with retigabine IR in the parent study, RGB113905, and who were thought to have benefitted from treatment will be provided continued access to retigabine IR.

NCT ID: NCT01318018 Completed - Depression Clinical Trials

Investigation on the Value of Bilateral Index (BIS) Monitoring for Magnetic Seizure Versus Electroconvulsive Therapy

Start date: February 2011
Phase:
Study type: Observational

Electroconvulsive therapy (ECT) has been shown to be an effective treatment for patients suffering from depression, who do not respond to medical treatment. However it is often dismissed by patients, who feel uncomfortably about the application of electric shocks to their heads. In 2000, magnetic seizure therapy (MST) has been introduced which uses magnetism instead of electricity to evoke convulsions. MST seems to be as effective as ECT in terms of its antidepressant potency but may be associated with less severe cognitive side effects. Control of anaesthesia during seizure therapy is demanding since light anesthesia might be associated with awareness, whereas deep anesthesia impedes the antidepressant effect of the convulsion. Therefore, Bispectral index (BIS) monitoring is frequently used to tailor anaesthesia for ECT, however little is known about BIS following MST. The investigators hypothesize that in comparing MST with ECT, (a) patients show a faster increase in BIS and that (b)less left-right differences occur in BIS.

NCT ID: NCT01292837 Completed - Epilepsy Clinical Trials

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Start date: February 2011
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy and safety of Levetiracetam dry syrup at doses up to 60 mg/kg/day or 3000 mg/day used as adjunctive therapy in Japanese pediatric patients aged ≥4 to <16 years with uncontrolled Generalized Tonic-Clonic (GTC) seizures despite treatment with 1 or 2 Anti-Epileptic Drugs (AEDs).

NCT ID: NCT01291992 Completed - Clinical trials for Non-convulsive Seizures

Seizures After Cardiac Surgery -- A Study With Continuous EEG Monitoring

Start date: September 2010
Phase: N/A
Study type: Observational

The aim of this study is to determine the frequency of nonconvulsive seizures after cardiac surgery using an electroencephalogram or EEG, which records brainwaves through the scalp.

NCT ID: NCT01284556 Completed - Epilepsy Clinical Trials

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

Start date: November 2010
Phase: Phase 3
Study type: Interventional

Primary: - to evaluate the efficacy of phenobarbital in reducing seizure frequency. Secondary: - to confirm dose response relationship, - to assess the effects on Type I seizures, - to assess the safety of phenobarbital - to assess the drug tolerability.